Published: 22 April 2016
Author(s): Christa C. van Bunderen, Paul Lips, Mark H. Kramer, Madeleine L. Drent
Issue: April 2016
Section: Original article

Current guidelines state that the goals of growth hormone (GH) therapy in adults should be an appropriate clinical response, avoidance of side effects, and an IGF-1 value within the age-adjusted reference range. There are no published studies on the target level for IGF-1 that offer specific guidance in this regard.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.